Multibagger Alert: Sudarshan Pharma Industries Declares ₹188.34 Crore Fundraise, Stock Soars Over 525% in One Year

Vijay Singh
3 Min Read

The Indian stock market will see Sudarshan Pharma Industries Ltd in focus as trading resumes at 9:15 AM on Monday. This small-cap stock, priced below ₹50, has captured investor attention with its stellar performance, emerging as one of the multibagger stocks in the Indian market over the last year. The company recently announced a preferential share issuance worth ₹188.34 crore, signaling a strategic move to bolster its growth and financial stability.

Preferential Share Issue to Fund Growth

Sudarshan Pharma Industries informed stock exchanges on Friday about its decision to raise ₹188.34 crore through preferential shares. According to the company, the fundraise will involve the issuance of 4.3 crore fully convertible warrants, which can be converted into an equivalent number of equity shares.

Key highlights of the preferential issue:

  • The issue price will be higher than the floor price determined under SEBI ICDR Regulations, 2018.
  • The issuance is aimed at enhancing operational capabilities, supporting business growth, and ensuring long-term financial stability.
  • The allocation will be made to both promoter/promoter group and non-promoter public categories.
  • The move is subject to shareholder approval and regulatory clearances.

This development comes as part of Sudarshan Pharma’s strategy to expand its footprint and capitalize on emerging opportunities in the pharmaceutical sector.


Sudarshan Pharma Share Price Performance

Sudarshan Pharma Industries has been a remarkable performer in the Indian stock market, delivering exceptional returns across different timeframes:

  • 1 Month: Up by 14%.
  • 6 Months: Surged by a massive 450%.
  • 1 Year: Skyrocketed 525%, cementing its position as a multibagger stock.
  • 2025 Performance: Outperformed frontline indices with an 8% return, while broader indices delivered zero returns.

This phenomenal growth reflects the stock’s ability to consistently outperform market benchmarks, making it an attractive pick for small-cap investors.


Key Stock Metrics

  • Market Cap: ₹1,174 crore (as of Friday).
  • Trade Volume: 52,000 shares traded on the BSE.
  • 52-Week High: ₹53.50 per share.
  • 52-Week Low: ₹5.82 per share.

Notably, Sudarshan Pharma is available for trading exclusively on the BSE. The stock ended Friday’s session firmly, showcasing investor confidence ahead of its preferential issue.


What Makes Sudarshan Pharma a Multibagger?

Sudarshan Pharma Industries has emerged as a multibagger due to a combination of robust financial performance, strategic growth initiatives, and favorable market dynamics. The company’s decision to issue preferential shares demonstrates its proactive approach to strengthening its financial base and fueling future growth.

Investors will closely watch Sudarshan Pharma’s performance in Monday’s trading session, especially as the stock continues to gain momentum in the small-cap space. Keep an eye on this multibagger as it charts its growth trajectory in the Indian pharmaceutical market.

Share This Article